Correlation Between Jagsonpal Pharmaceuticals and Eros International

Can any of the company-specific risk be diversified away by investing in both Jagsonpal Pharmaceuticals and Eros International at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Jagsonpal Pharmaceuticals and Eros International into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Jagsonpal Pharmaceuticals Limited and Eros International Media, you can compare the effects of market volatilities on Jagsonpal Pharmaceuticals and Eros International and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Jagsonpal Pharmaceuticals with a short position of Eros International. Check out your portfolio center. Please also check ongoing floating volatility patterns of Jagsonpal Pharmaceuticals and Eros International.

Diversification Opportunities for Jagsonpal Pharmaceuticals and Eros International

-0.8

Correlation Coefficient

Jagsonpal Pharmaceuticals  Eros International

Pay attention - limited upside

The 3 months correlation between Jagsonpal and Eros is -0.8. Overlapping area represents the amount of risk that can be diversified away by holding Jagsonpal Pharmaceuticals Limi and Eros International Media in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eros International Media and Jagsonpal Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Jagsonpal Pharmaceuticals Limited are associated (or correlated) with Eros International. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eros International Media has no effect on the direction of Jagsonpal Pharmaceuticals i.e., Jagsonpal Pharmaceuticals and Eros International go up and down completely randomly.

Pair Corralation between Jagsonpal Pharmaceuticals and Eros International

Assuming the 90 days trading horizon Jagsonpal Pharmaceuticals Limited is expected to generate 0.94 times more return on investment than Eros International. However, Jagsonpal Pharmaceuticals Limited is 1.07 times less risky than Eros International. It trades about 0.06 of its potential returns per unit of risk. Eros International Media is currently generating about -0.03 per unit of risk. If you would invest  31,990  in Jagsonpal Pharmaceuticals Limited on September 29, 2024 and sell it today you would earn a total of  31,975  from holding Jagsonpal Pharmaceuticals Limited or generate 99.95% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	98.93%
Values	Daily Returns

Jagsonpal Pharmaceuticals Limi  vs.  Eros International Media

Jagsonpal Pharmaceuticals

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Jagsonpal Pharmaceuticals Limited are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady basic indicators, Jagsonpal Pharmaceuticals demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Eros International Media

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Eros International Media has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's fundamental indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Jagsonpal Pharmaceuticals and Eros International

The main advantage of trading using opposite Jagsonpal Pharmaceuticals and Eros International positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Jagsonpal Pharmaceuticals position performs unexpectedly, Eros International can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eros International will offset losses from the drop in Eros International's long position.

The idea behind Jagsonpal Pharmaceuticals Limited and Eros International Media pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.